Professor Tim Greet Receives British Veterinary Association’s Prestigious Chiron Award

Professor Tim Greet BVMS MVM Cert EO DESTS Dip ECVS FRCVS was on Saturday announced as the recipient of the British Veterinary Association’s prestigious Chiron Award.
The award, which marks outstanding contributions to veterinary science or for outstanding services to the profession, judged in either case as being of a calibre commanding international or inter-professional recognition, [...]

Drug Information Association 2nd Annual Clinical Forum: Data Driven Drug Development Decisions

Following a very successful first event in 2007, the Drug Information Association’s (DIA’s) 2nd Annual Clinical Forum: Data Driven Drug Development Decisions (October 20-23, 2008; Ljubljana, Slovenia) will focus on clinical data. New and experienced colleagues in the field of clinical and safety data management, clinical research and operations, statistics, medical information, pharmacovigilance, information [...]

Devising A Plan To Cope With Lewy Body Dementia – MayoClinic.com

Lewy body dementia is a progressive brain disease and the second leading cause of degenerative dementia in the elderly. Dementia with Lewy bodies (DLB), which is the clinical name, accounts for up to 20 percent of all dementia cases, or 800,000 patients in the United States.

Understanding Embryo Implantation Offers Insight Into Infertility

A process that governs embryo implantation in the womb in humans has been identified for the first time. The Oxford University research, published in the journal PNAS , could shed light on what goes wrong when embryos fail to implant in the lining of the womb, a leading cause of infertility.

GI Dynamics Announces Promising Multi-Center Safety And Efficacy Data Of EndoBarrier™ Gastrointestinal Liner For Pre-Surgical Weight Loss

GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced new data regarding the EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes. New data from a multi-center, randomized clinical trial indicate that the EndoBarrier is a safe, [...]